摘要
面对全球严峻的公共健康形势, WTO 《TRIPs协定》和《修改〈TRIPs协定〉议定书》构建了药品专利强制许可制度。本文认为,我国药品专利强制许可制度一直处于"零实施"状态的原因不仅有指导思想上的困惑与担忧,还有制度上的缺陷。对药品专利强制许可应当"慎用而善用",努力在立法上作科学而完善的制度设计,以简洁而流畅的程序保障制度的实施,同时在司法上探索开辟新途径,切实提高我国药品的可及性,以保障公共健康利益的实现。
In the face of the serious public health situation in the world,the compulsory license system of drug patents has been established in the WTO TRIPs Agreement and the Protocol of Amendment to TRIPs Agreement.The reason why China’s compulsory license system of drug patents has been in the state of 'zero implementation' is not only the confusion and concern in guiding ideology,but also the defects in system.Under the guidance of the thought of 'cautious and good use',we should make a scientific and perfect system design in legislation,implement a simple and smooth procedural safeguard system,and explore new ways in judicature to improve the accessibility of drugs and protect public health interests.
出处
《行政与法》
2019年第2期95-105,共11页
Administration and Law
关键词
专利强制许可
专利药品
公共健康
patented medicine
compulsory licensing of patent
public health
